Esperion Therapeutics Inc (ESPR)

Aug 14, 2025

What MACD signals say about Esperion Therapeutics Inc.Chart Signals & Verified Technical Signals - Newser

Aug 14, 2025

Aug 14, 2025

Can Esperion Therapeutics Inc. Regain Momentum After BreakdownJuly 2025 Rallies & Safe Entry Trade Reports - beatles.ru

Aug 14, 2025

Aug 13, 2025

What earnings revisions data tells us about Esperion Therapeutics Inc.Quarterly Profit Review & Real-Time Buy Signal Notifications - Newser

Aug 13, 2025

Aug 13, 2025

Real time scanner hits for Esperion Therapeutics Inc. explainedJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - Newser

Aug 13, 2025

Aug 13, 2025

Esperion Therapeutics Inc. stock outlook for YEARWeekly Volume Report & Real-Time Market Sentiment Reports - Newser

Aug 13, 2025

Aug 13, 2025

Is a relief rally coming for Esperion Therapeutics Inc. holdersTrade Signal Summary & Daily Profit Maximizing Tips - Newser

Aug 13, 2025

Aug 13, 2025

Wall Street Zen Upgrades Esperion Therapeutics (NASDAQ:ESPR) to "Hold" - MarketBeat

Aug 13, 2025

Aug 12, 2025

Esperion Delays Q2 2025 Financial Report Filing - MSN

Aug 12, 2025

Aug 12, 2025

Competitive Positioning of Esperion Therapeutics Inc.: Is It Leading or LaggingFree Intraday Trend Analysis for Fast Gains - Newser

Aug 12, 2025

Aug 10, 2025

Published on: 2025-08-10 18:32:11 - beatles.ru

Aug 10, 2025

Aug 10, 2025

FY2025 EPS Estimates for ESPR Boosted by Cantor Fitzgerald - Defense World

Aug 10, 2025

Aug 09, 2025

Esperion Therapeutics Inc. At Decision Level — Rebound or ResistanceExpert Verified Stock Trade Ideas Backed by Data - beatles.ru

Aug 09, 2025

Aug 09, 2025

ESPR's Q2 Earnings & Revenues Trump Estimates, Stock Rises - MSN

Aug 09, 2025

Aug 09, 2025

Esperion Therapeutics (NASDAQ:ESPR) Upgraded to Hold at Wall Street Zen - Defense World

Aug 09, 2025

Aug 09, 2025

HC Wainwright Issues Positive Outlook for ESPR Earnings - Defense World

Aug 09, 2025

Aug 08, 2025

Published on: 2025-08-08 10:01:24 - beatles.ru

Aug 08, 2025

Aug 07, 2025

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) for New Employees - AInvest

Aug 07, 2025

Aug 07, 2025

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewswire

Aug 07, 2025

Aug 07, 2025

Esperion Grants 73,500 RSUs with 4-Year Vesting Schedule to Attract Top Talent - Stock Titan

Aug 07, 2025

Aug 07, 2025

Esperion rises after revenue beat, Q1 profitability expectation - MSN

Aug 07, 2025

Aug 06, 2025

Esperion Therapeutics’ Earnings Call Highlights Growth - The Globe and Mail

Aug 06, 2025

Aug 06, 2025

Esperion (ESPR) Q2 Revenue Jumps 12% - AOL.com

Aug 06, 2025

Aug 06, 2025

Esperion Therapeutics (ESPR) Reports Q2 Loss, Tops Revenue Estimates - MSN

Aug 06, 2025

Aug 06, 2025

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 06, 2025

Aug 06, 2025

Esperion expects sustainable profitability in Q1 2026 as double-digit growth continues - MSN

Aug 06, 2025

Aug 06, 2025

Esperion Therapeutics: Q2 Earnings Snapshot - New Haven Register

Aug 06, 2025

Aug 06, 2025

What institutional flow reveals about Esperion Therapeutics Inc.Long-Term Stock Growth Forecast Insights - Newser

Aug 06, 2025

Aug 06, 2025

Esperion Therapeutics Inc (ESPR) Q2 2025 Earnings Call Highlights: Strong US Net Product ... By GuruFocus - Investing.com Canada

Aug 06, 2025

Aug 06, 2025

Esperion Therapeutics Reports Strong Q2 2025 Growth - TipRanks

Aug 06, 2025

Aug 05, 2025

Esperion Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat

Aug 05, 2025

Aug 05, 2025

Will Esperion Therapeutics Stock Surge Sustain? - StocksToTrade

Aug 05, 2025

Aug 05, 2025

Esperion's Q2 2025 Earnings Call: Unpacking Key Contradictions in Market Access, Growth Strategies, and Revenue Projections - AInvest

Aug 05, 2025

Aug 05, 2025

Transcript : Esperion Therapeutics, Inc., Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener

Aug 05, 2025

Aug 05, 2025

Esperion Therapeutics, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:ESPR) - Seeking Alpha

Aug 05, 2025

Aug 05, 2025

Earnings call transcript: Esperion Therapeutics Q2 2025 beats forecasts, stock rises - Investing.com Canada

Aug 05, 2025

Aug 05, 2025

Earnings call transcript: Esperion Therapeutics Q2 2025 beats forecasts, stock rises By Investing.com - Investing.com South Africa

Aug 05, 2025

Aug 05, 2025

Esperion Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 05, 2025

Aug 05, 2025

Esperion Therapeutics Q2 Earnings: Narrower Loss and Revenue BeatNews and Statistics - IndexBox

Aug 05, 2025

Aug 05, 2025

Esperion Reports 12% Revenue Growth in Q2 2025 with Significant Increases in U.S. Product Sales and Settlements with ANDA Filers - Quiver Quantitative

Aug 05, 2025

Aug 05, 2025

Esperion Therapeutics Q2 revenue up 12%, operating profit beats estimates - MarketScreener

Aug 05, 2025

Aug 05, 2025

Esperion Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Aug 05, 2025

Aug 05, 2025

Esperion Reports Record 42% Revenue Growth, Secures Patent Protection Until 2040 in Breakthrough Quarter - Stock Titan

Aug 05, 2025

Aug 04, 2025

How many analysts rate Esperion Therapeutics Inc. as a “Buy”Discover top stock picks for aggressive growth - Jammu Links News

Aug 04, 2025

Aug 03, 2025

Is Esperion Therapeutics Inc. a good long term investmentAchieve rapid financial growth with expert help - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are the latest earnings results for Esperion Therapeutics Inc.Free Market Dynamics Reports - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are the technical indicators suggesting about Esperion Therapeutics Inc.Strong return on investment - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Esperion Therapeutics Inc. stock in 2025Rapid wealth multiplication - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Esperion Therapeutics Inc. stock overvalued or undervaluedAchieve breakthrough performance with smart picks - Jammu Links News

Aug 03, 2025